Abstract
Germline CDH1 defects are related with the development of multiple cancers due its pleiotropic nature. These several conditions are associated with various risks of penetrance and with different clinical management strategies. In this clinical review, we described the penetrance risks of gastric, breast, prostate, and colorectal cancers, in CDH1 carriers, within as well as outside the familial setting, and the best approaches to manage each risk, using either prophylactic surgery or surveillance.
Author supplied keywords
Cite
CITATION STYLE
Corso, G. (2022, June 1). Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management. Journal of Surgical Oncology. John Wiley and Sons Inc. https://doi.org/10.1002/jso.26847
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.